These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder. Chavez B, Sopko MA, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT. Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858 [Abstract] [Full Text] [Related]
23. Transdermal methylphenidate system: old wine in a new bottle. Bukstein OG. Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):661-5. PubMed ID: 19442029 [Abstract] [Full Text] [Related]
26. Cerebral vasculitis following oral methylphenidate intake in an adult: a case report. Thomalla G, Kucinski T, Weiller C, Röther J. World J Biol Psychiatry; 2006 Jun; 7(1):56-8. PubMed ID: 16428221 [Abstract] [Full Text] [Related]
28. Status epilepticus associated with the administration of long-acting methylphenidate in a 7-year-old girl. Goetz M, Surman CB, Mlynarova E, Krsek P. J Clin Psychopharmacol; 2012 Apr; 32(2):300-2. PubMed ID: 22388167 [No Abstract] [Full Text] [Related]
29. A case of acute cardiomyopathy and pericarditis associated with methylphenidate. Dadfarmay S, Dixon J. Cardiovasc Toxicol; 2009 Mar; 9(1):49-52. PubMed ID: 19296063 [Abstract] [Full Text] [Related]
31. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder. Cox DJ, Mikami AY, Cox BS, Coleman MT, Mahmood A, Sood A, Moore M, Burket R, Merkel RL. Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816 [No Abstract] [Full Text] [Related]
32. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD? Niederhofer H. Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351 [No Abstract] [Full Text] [Related]
33. Methylphenidate-induced acute orofacial and extremity dyskinesia. Yilmaz AE, Donmez A, Orun E, Tas T, Isik B, Sonmez FM. J Child Neurol; 2013 Jun; 28(6):781-3. PubMed ID: 22791547 [Abstract] [Full Text] [Related]
34. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'. Olders H. J Pediatr Psychol; 2009 Jun; 34(1):108-9; author reply 110-2. PubMed ID: 19136567 [No Abstract] [Full Text] [Related]
38. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death. Knight M. Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281 [No Abstract] [Full Text] [Related]
39. Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder. Hammerness P, Wilens T, Mick E, Spencer T, Doyle R, McCreary M, Becker J, Biederman J. J Pediatr; 2009 Jul; 155(1):84-9, 89.e1. PubMed ID: 19394037 [Abstract] [Full Text] [Related]
40. Excessive talking triggered by methylphenidate in a boy with ADHD. Ghanizadeh A. Pharmacopsychiatry; 2009 Jan; 42(1):35-6. PubMed ID: 19153945 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]